Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.51 |
| ▸ | NPY4R | P50391 | 7/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.51 |
| ▸ | NPY1R | P25929 | 5/20 | 0.51 |
| ▸ | CXCR4 | P61073 | 4/20 | 0.49 |
| ▸ | TFPI | P10646 | 4/20 | 0.49 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.46 |
| ▸ | CALCR | P30988 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30063864 | 0.93 | NPY2R (0.49) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30562225 | 0.87 | NPY2R (0.56) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31670624 | 0.86 | TFPI (0.49) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31670615 | 0.86 | NPY2R (0.55) | NPY2RNPY4RNPY5RNPY1RRAMP3 | |
| SCHEMBL31031494 | 0.85 | CXCR4 (0.49) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30900794 | 0.85 | CXCR4 (0.50) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30980069 | 0.85 | KDM1A (0.53) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL29570031 | 0.85 | NMUR2 (0.50) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL29568631 | 0.84 | RAMP3 (0.50) | CXCR4RAMP3CALCR | |
| SCHEMBL29568528 | 0.84 | RAMP3 (0.50) | CXCR4RAMP3CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897693-B1 | SYNTHETIC AND RECOMBINANT COLLAGEN PEPTIDES HAVING BIOLOGICAL ACTIVITY | GELITA AG (DE) | 2025-08-06 | — | — | EP | disclosed |